InvestorsHub Logo
Followers 468
Posts 26926
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 129

Tuesday, 10/29/2013 9:39:37 AM

Tuesday, October 29, 2013 9:39:37 AM

Post# of 170
8:14AM Sucampo Pharma: Numab Reacquires Advanced Compound from Sucampo (SCMP) 6.62 : Co announced that it has reacquired the rights to ND003, a bispecific anti-IL5RxCD3 antibody fragment for the targeted lysis of eosinophils in severe asthma, from Sucampo AG, a subsidiary of Sucampo Pharmaceuticals, Inc.